In a column interesting, thought-provoking, informative and a bit infuriating all at the same time, Jon Markman says Endo Pharmaceuticals, makers of Percocet, is a "go-to" stock for next year?
Why? Aging baby boomers, he says, and that, even if you have to pay out of pocket, you'll cough up.
No comments:
Post a Comment
Your comments are appreciated, as is at least a modicum of politeness.
Comments are moderated, so yours may not appear immediately.
Due to various forms of spamming, comments with professional websites, not your personal website or blog, may be rejected.